CPC A61K 9/0024 (2013.01) [A61F 2/022 (2013.01); A61K 31/337 (2013.01); A61K 31/397 (2013.01); A61K 31/436 (2013.01); A61K 31/65 (2013.01); A61K 31/7036 (2013.01); A61K 35/28 (2013.01); A61K 38/14 (2013.01); A61K 38/1866 (2013.01); A61K 38/22 (2013.01); A61K 39/395 (2013.01); A61K 47/02 (2013.01); A61M 39/0247 (2013.01); A61M 2039/027 (2013.01); A61M 2039/0261 (2013.01); A61M 2039/0276 (2013.01); A61M 2205/04 (2013.01)] | 13 Claims |
1. A medical device, comprising:
an apertured metallic capsule; and
a substrate having a nanophase tubular structure, the nanophase tubular structure including a plurality of nanotubes integrated with the apertured metallic capsule and configured to facilitate fluid and diffusion and exchange to the apertured metallic capsule.
|